173 related articles for article (PubMed ID: 25942998)
1. FDAMA Section 114: Why the Renewed Interest?
Perfetto EM; Burke L; Oehrlein EM; Gaballah M
J Manag Care Spec Pharm; 2015 May; 21(5):368-74. PubMed ID: 25942998
[TBL] [Abstract][Full Text] [Related]
2. AMCP Partnership Forum: FDAMA Section 114-Improving the Exchange of Health Care Economic Data.
J Manag Care Spec Pharm; 2016 Jul; 22(7):826-31. PubMed ID: 27333323
[TBL] [Abstract][Full Text] [Related]
3. US FDA Modernization Act, section 114: uses, opportunities and implications for comparative effectiveness research.
Neumann PJ; Lin PJ; Hughes TE
Pharmacoeconomics; 2011 Aug; 29(8):687-92. PubMed ID: 21732704
[TBL] [Abstract][Full Text] [Related]
4. AMCP Seeks an End to 20 Years Of Confusion Over FDAMA Section 114.
Dalzell MD
Manag Care; 2016 Sep; 25(9):43-45. PubMed ID: 28121576
[TBL] [Abstract][Full Text] [Related]
5. AMCP Partnership Forum: Enabling the Exchange of Clinical and Economic Information Pre-FDA Approval.
J Manag Care Spec Pharm; 2017 Jan; 23(1):105-112. PubMed ID: 28025919
[TBL] [Abstract][Full Text] [Related]
6. When Does FDAMA Section 114 Apply? Ten Case Studies.
Neumann PJ; Saret CJ
Value Health; 2015 Jul; 18(5):682-9. PubMed ID: 26297097
[TBL] [Abstract][Full Text] [Related]
7. Drug company advertising in medical journals about the health-economic advantages of their products for 2000-2006 versus 1990-1999.
Palmer JA; Timm AR; Neumann PJ
J Manag Care Pharm; 2008 Oct; 14(8):749-55. PubMed ID: 18983204
[TBL] [Abstract][Full Text] [Related]
8. What ever happened to FDAMA Section 114? A look back after 10 years.
Neumann PJ
Value Health; 2009; 12(2):189-90. PubMed ID: 18657100
[No Abstract] [Full Text] [Related]
9. A Legislative/Legal History of Prescription Drug Advertising and Promotion Regulation.
Li S; Gibbs I
J Pharm Pharm Sci; 2021; 24():381-389. PubMed ID: 34314671
[TBL] [Abstract][Full Text] [Related]
10. Opinions regarding the Academy of Managed Care Pharmacy dossier submission guidelines: results of a small survey of managed care organizations and pharmaceutical manufacturers.
Nichol MB; Knight TK; Epstein J; Honda DH; Tretiak R
J Manag Care Pharm; 2007 May; 13(4):360-71. PubMed ID: 17506602
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the Level of Satisfaction and Unmet Data Needs for Specialty Drug Formulary Decisions in the United States.
Choi Y; Navarro RP
J Manag Care Spec Pharm; 2016 Apr; 22(4):368-75. PubMed ID: 27023690
[TBL] [Abstract][Full Text] [Related]
12. Implementing CER: what will it take?
Biskupiak JE; Dunn JD; Holtorf AP
J Manag Care Pharm; 2012 Jun; 18(5 Supp A):S19-29. PubMed ID: 22663296
[TBL] [Abstract][Full Text] [Related]
13. The Academy of Managed Care Pharmacy Format for Formulary Submissions: an evolving standard--a Foundation for Managed Care Pharmacy Task Force report.
Fry RN; Avey SG; Sullivan SD
Value Health; 2003; 6(5):505-21. PubMed ID: 14627057
[TBL] [Abstract][Full Text] [Related]
14. Explanations and unresolved issues pertaining to the development of the Nuclear Pharmacy Compounding Guidelines.
Hung JC; Augustine SC; Cheng KT; Green RL; Hopkins WM; Laven DL; Nelson BR; Petry NA; Ponto JA; Quinton TM; Swanson DP
J Am Pharm Assoc (Wash); 2002; 42(5):789-98. PubMed ID: 12269713
[TBL] [Abstract][Full Text] [Related]
15. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
16. The regulation of patient-reported outcome claims: need for a flexible standard.
Morris LA; Miller DW
Value Health; 2002; 5(4):372-81. PubMed ID: 12102699
[TBL] [Abstract][Full Text] [Related]
17. The FDA's regulation of pharmaceutical communications in the context of managed care: a suggested approach.
Kuhlik BN
Food Drug Law J; 1995; 50(1):23-48. PubMed ID: 10342984
[No Abstract] [Full Text] [Related]
18. Got CER? Educating Pharmacists for Practice in the Future: New Tools for New Challenges.
Perfetto EM; Anyanwu C; Pickering MK; Zaghab RW; Graff JS; Eichelberger B
J Manag Care Spec Pharm; 2016 Jun; 22(6):609-16. PubMed ID: 27231789
[TBL] [Abstract][Full Text] [Related]
19. The AMCP Format for Formulary Submissions: Welcome to Version 4.0.
J Manag Care Spec Pharm; 2016 May; 22(5):444-6. PubMed ID: 27123906
[TBL] [Abstract][Full Text] [Related]
20. Is Real-World Evidence Used in P&T Monographs and Therapeutic Class Reviews?
Hurwitz JT; Brown M; Graff JS; Peters L; Malone DC
J Manag Care Spec Pharm; 2017 Jun; 23(6):613-620. PubMed ID: 28530524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
